InflaRx N.V.(IFRX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,520 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
IFRX Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for InflaRx N.V. (IFRX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IFRX at 29.7/100 on a 32-signal composite quality model, placing it at rank #2,520 of 2,961 stocks — the bottom half of the AI-ranked universe. Top institutional holders of IFRX by reported 13-F value include SUVRETTA CAPITAL MANAGEMENT, TCG Crossover Management, FMR, based on the most recent SEC filings. IFRX trades on the Nasdaq exchange and files with the SEC under CIK 1708688. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IFRX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InflaRx N.V. directly from SEC EDGAR.
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-82.3% YoYTotal Assets
-27.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $29.3K -82.3% | $165.8K +162.8% | $63.1K | — | — | — |
| Total Assets | $55.2M -27.4% | $76.0M -36.8% | $120.2M +17.4% | $102.4M -18.2% | $125.1M +41.9% | $88.2M |
Get alerted when IFRX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for InflaRx N.V. including:
Top Institutional Holders of IFRX
SUVRETTA CAPITAL MANAGEMENT, LLC
$51.4M22,933,910 shTCG Crossover Management, LLC
$32.5M14,500,000 shFMR LLC
$18.3M8,163,341 shCommodore Capital LP
$16.4M7,300,000 shSpruce Street Capital LP
$12.0M5,352,198 sh683 Capital Management, LLC
$11.3M5,065,000 shFARALLON CAPITAL MANAGEMENT LLC
$7.4M3,325,000 shStemPoint Capital LP
$7.2M3,228,255 shGREAT POINT PARTNERS LLC
$6.8M3,046,557 shADAR1 Capital Management, LLC
$6.7M3,000,000 sh
| Fund | Value | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | $51.4M | 22,933,910 |
| TCG Crossover Management, LLC | $32.5M | 14,500,000 |
| FMR LLC | $18.3M | 8,163,341 |
| Commodore Capital LP | $16.4M | 7,300,000 |
| Spruce Street Capital LP | $12.0M | 5,352,198 |
| 683 Capital Management, LLC | $11.3M | 5,065,000 |
| FARALLON CAPITAL MANAGEMENT LLC | $7.4M | 3,325,000 |
| StemPoint Capital LP | $7.2M | 3,228,255 |
| GREAT POINT PARTNERS LLC | $6.8M | 3,046,557 |
| ADAR1 Capital Management, LLC | $6.7M | 3,000,000 |
More Healthcare Companies
View all Healthcare →Put IFRX on your watchlist
Track score changes the day InflaRx N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IFRX a good stock to buy?
13F Pro's AI-powered analysis of InflaRx N.V. (IFRX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IFRX are available on the IFRX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. IFRX is classified as a small company.
Which hedge funds own IFRX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IFRX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InflaRx N.V.'s investment landscape.